The global electrophysiology market is poised for significant growth, projected to expand from USD 4,350.7 billion in 2024 to USD 9,078.4 billion by 2034, at a robust CAGR of 7.6%. This remarkable growth is driven by the rising adoption of minimally invasive electrophysiology therapies for cardiac diagnostics and ablation procedures. Electrophysiology laboratory devices emerged as the dominant segment, accounting for the largest market share. Increasing demand for advanced diagnostic tools and efficient treatment options for cardiac arrhythmias is fueling innovation and adoption across the global healthcare landscape.
NEWARK, DE / ACCESSWIRE / December 17, 2024 / The global Electrophysiology Market is expected to experience robust growth from 2024 to 2034, driven by advancements in medical technology, rising prevalence of cardiovascular diseases, and increased demand for minimally invasive procedures. The market size in 2024 is projected to be USD 4,350.7 billion and is expected to reach USD 9,078.4 billion by 2034, growing at a compound annual growth rate (CAGR) of 7.6%. This growth is primarily fueled by innovations in electrophysiology devices, the aging population, and increasing awareness about the importance of heart health.
Electrophysiology is a critical segment in the healthcare industry, encompassing technologies and treatments used to diagnose and treat heart rhythm disorders. The rising global burden of cardiovascular diseases is a major factor propelling market growth. Additionally, advances in diagnostic devices, such as electrophysiology catheters and 3D mapping systems, are significantly contributing to the market's expansion. The increasing number of healthcare facilities and the growing adoption of minimally invasive techniques are also boosting demand for electrophysiology services.
The market is experiencing heightened activity from both established and emerging companies in the medical device sector, focusing on enhancing product offerings and expanding geographical reach. Innovations in electrophysiology devices, particularly those that offer enhanced precision and improved patient outcomes, are expected to dominate market trends over the coming years. The integration of artificial intelligence (AI) and machine learning (ML) in electrophysiology diagnostics is opening up new opportunities for growth and development in the industry.
As healthcare systems worldwide continue to evolve, there is a growing need for more efficient, cost-effective treatment options, particularly for cardiovascular diseases. This demand for advanced diagnostic tools and treatments is expected to remain strong, driving the electrophysiology market's growth trajectory through 2034. The increasing importance of personalized medicine and the integration of telemedicine platforms into patient care will also play pivotal roles in shaping the market's future.
What Is The Extent Of The Minimal Invasive Electrophysiology Procedure Impacting The Market?
The invasive surgical interventions are associated with several risks for patients with pre-existing medical comorbidities such as hypertension, diabetes, etc. Also, the prevalence of cardiac arrhythmias including atrial fibrillation, atrial flutter, Wolff-Parkinson-White syndrome, and others is on its rise, therefore, it necessitates a safer, cost-effective and minimally invasive interventional procedure for the cardiac arrhythmia.
The American Heart Association has stated that over 2.7 million Americans suffers from atrial fibrillation. The minimally invasive technology offered by cardiac ablation catheters and diagnostic catheters imperatively drive the electrophysiology market's growth spurt. The manufacturers are focused to provide advanced ablation and diagnostic catheters, and devices which are minimally invasive and offers a short recovery period.
Key Takeaways from Market Study:
Increased Adoption of Minimally Invasive Techniques: Growth in non-invasive diagnostic and therapeutic methods.
Technological Innovations: AI, machine learning, and robotic assistance are reshaping electrophysiology procedures.
Healthcare Accessibility: Expanding healthcare infrastructure in emerging markets is boosting the demand for electrophysiology treatments.
Cardiovascular Disease Burden: Rising global cardiovascular diseases continue to drive demand for electrophysiology services.
"The Electrophysiology Market is set to experience significant growth over the next decade due to the increasing prevalence of cardiovascular diseases and the rapid advancements in medical technologies. Key players are investing heavily in product innovation, particularly in electrophysiology catheters and imaging systems, as these technologies offer higher precision, shorter recovery times, and improved patient outcomes. Moreover, the integration of AI and robotics is likely to revolutionize diagnostic and treatment capabilities in the near future, further driving market expansion." Says Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.)
Get Complete Full Report: https://www.futuremarketinsights.com/reports/electrophysiology-market
What is the Commercial Potential of the Smart Technologies in Electrophysiology Devices?
Manufacturers are increasingly including smart and next-generation technologies. The advanced cardiac electromapping machines equipped with next generation basket catheter scanning offers expedited, detailed and efficient cardiac tissue mapping. The advanced technology of contact force-sensing ablation catheters offers high precision lesion formation.
Manufacturers have been seen at the forefront to strengthen their electrophysiology portfolio. Several companies have undergone acquisitions to expand their electrophysiology offerings. For instance, On June 05, 2018, Philips Healthcare acquired EPD, to strengthen the electrophysiology ablation image-guiding systems. Baylis Medical and Japan Lifeline collaborated to penetrate their advanced electrophysiology procedure solutions in the Europe and North America region.
Several players such as Johnson & Johnson (Biosense Webster, Inc.), Abbott Laboratories, Acutus Medical Inc. and Microport Scientific Corporation have recently earned approvals and launched multiple electrophysiology catheters and mapping systems.
How are Innovations Driving Electrophysiology Market?
Manufacturers are focusing on alleviating issues associated with the conventional cardiac ablation catheters, diagnostic catheters, cardiac mapping machine, and access devices. The electrophysiology market has been introduced with next-generation electrophysiology devices, loaded with advanced features that offer elevated safety and precision.
The conventional ablation catheters have been associated with off-targeting ablations, burns and limited flexibility to access the target tissue site. The latest ablation catheters include contact force-sensing technology which provides control and precision for ablation, balloon inflation pulmonary vein isolation that allows to access the challenging anatomy of the target tissue, and irrigated tip technology avoids ablation induced burns to the healthy cardiac tissues. Such advanced technology elevates the adoption of catheter ablation procedures by nullifying the potential risks.
The cradiac electromapping machines are loaded with next-generation basket catheter which rapidly scans cardiac tissues point-by-point, also the use of a magnetic sensor or use of multiple ultrasound electrode basket for expedited and precise scanning.
Medical devices in this decade are getting smarter, which are not just technological advancements, but also an essentiality amid the challenges of the pandemic. The interventionalists cannot afford to delay the cardiac therapies and on the same time, the hospital visits are also needed to be restricted to avoid hospital-acquired infection. Manufacturers have started including digital cloud technology to access and manage electrophysiology data for the monitoring of the cardiac rhythm data. This nullifies the need of physically visiting the interventionalist.
Country-wise Insights
North America is well known for its strong healthcare infrastructure, emphasis on research and development, and availability of cutting-edge medical technologies. The electrophysiology market in the region is growing as a result of a favourable environment for the adoption of innovative treatment approaches such as electrophysiology.
The expanding prevalence of arrhythmias, the increasing number of ablation facilities and procedures, and the increased use of electrophysiology equipment are all driving the market in Europe. Meanwhile, the Asia-Pacific electrophysiology business is expected to provide opportunities for prominent manufacturers looking to expand their reach. The increasing frequency of atrial fibrillation, a growing senior population, rising healthcare costs, and technological breakthroughs in electrophysiology are some of the main drivers driving market expansion.
Country |
CAGR (2024 to 2034) |
United States |
9.6% |
Germany |
9.9% |
France |
8.7% |
India |
7.9% |
Canada |
8.8% |
Component Insights:
Electrophysiology Catheters: These devices are crucial for diagnosing and treating arrhythmias and are expected to dominate the market due to the increasing demand for minimally invasive procedures.
Electrophysiology Mapping Systems: With the development of 3D mapping systems, healthcare professionals can now provide more accurate and efficient treatment, which is driving the demand for these systems in electrophysiology applications.
Cardiac Ablation Devices: These devices, used to treat arrhythmias by destroying problematic tissue, are seeing a significant rise in adoption, particularly as the global demand for treatments for atrial fibrillation increases.
Wearable Devices: Devices that monitor heart rhythm abnormalities and provide data for real-time analysis are expected to witness substantial growth due to the increasing adoption of preventive healthcare.
What are the key drivers of atrial fibrillation prevalence in emerging economies?
The prevalence of atrial fibrillation (AF) in emerging economies is influenced by several key drivers, which contribute to the increasing incidence and impact of this condition. Here are the primary factors:
1. Aging Population
As populations in emerging economies age, the incidence of AF rises. Older adults are at a higher risk for developing AF due to age-related changes in cardiac structure and function.
2. Increasing Rates of Hypertension
Hypertension is a significant risk factor for AF, accounting for a large percentage of cases globally. In many emerging economies, the prevalence of hypertension is rising due to lifestyle changes, urbanization, and increased stress levels, contributing to higher AF rates
3. Obesity and Lifestyle Changes
The growing prevalence of obesity in emerging economies is linked to sedentary lifestyles and dietary changes. Obesity is associated with several cardiovascular risk factors, including hypertension and diabetes, which can lead to AF
4. Alcohol Consumption
Increased alcohol consumption has been observed in many emerging markets, which can exacerbate the risk of AF. Alcohol is known to trigger episodes of AF and contribute to overall cardiovascular health deterioration
5. Healthcare Access and Underdiagnoses
Limited access to healthcare services in some regions can lead to underdiagnoses and under treatment of AF. Many patients with AF may remain undiagnosed due to inadequate screening practices or lack of awareness among healthcare providers
Notable Developments in the Electrophysiology Market
In May 2022, BioSig Technologies, Inc., a medical technology company, released a commercial launch campaign. The company has previously contributed to many impactful initiatives to expedite the sales of the PURE EP system. The device has been approved by Food and Drug Administration 510(k), and it focuses on driving procedural efficacy and efficiency in cardiac electrophysiology.
In November 2021, India Medtronic Private Limited, which is a wholly-owned subsidiary of Medtronic plc, released the Arctic Front Cardiac Cry Ablation Catheter System. This is the first cry balloon catheter that has been approved by CDSCO to treat atrial fibrillation in India.
Key Electrophysiology Companies
Abbott Laboratories
Johnson & Johnson (Biosense Webster, Inc.)
Medtronic Plc
Boston Scientific Corporation
Japan Lifeline
Koninklijke Philips N.V.
Merit Medical Systems
Biotronik SE & Co. KG
Microport Scientific Corporation
APN Health, LLC
Baylis Medical Company, Inc.
Others
Old Source: Electrophysiology Market is poised to reach US$ 22.67 billion by 2033
Key Segments in the Electrophysiology Market Report
By Product Type:
-
Electrophysiology Laboratory Devices
3D Mapping Systems
Electrophysiology Recording Systems
Radiofrequency (RF) Ablation Systems
Intracardiac Echocardiography (Ice) Ultrasound Imaging Systems
Cardiac Stimulators
Others
-
Electrophysiology Ablation Catheters
Cryoablation Electrophysiology Catheters
Radiofrequency (RF) Ablation Catheters
Irrigated Tip RF Ablation Catheters
Laser Ablation Catheters
-
Electrophysiology Diagnostic Catheters
Conventional Electrophysiology Diagnostic Catheters
Advanced Electrophysiology Diagnostic Catheters
Ultrasound Electrophysiology Diagnostic Catheters
Access Devices
By Indication:
Atrial Fibrillation
Atrial Flutter
Wolff-Parkinson-White Syndrome (WPW)
Atrioventricular Nodal Reentry Tachycardia (AVNRT)
Ventricular tachycardia (VT)
Others
By End User:
Hospitals
Cardiac Catheterization Laboratories
Ambulatory Surgery Centers
By Region:
North America
Latin America
Europe
Asia Pacific
Middle East and Africa
Author
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
Explore FMI's Extensive Coverage in the Healthcare Domain:
The visual electrophysiology market is anticipated to flourish at a steady CAGR of 7.0% between 2023 and 2033.
The global Hospital Workforce Management Market is expected to be valued at USD 1,533.2 million in 2023.
The non-hospital-based point-of-care diagnostic products market is likely rise to a USD 12.9 billion valuation in 2022.
The global demand for hospital supplies is expected to increase at 3.7% CAGR over the forecast period from 2022 to 2032.
Future Market Insights' updated report on the electronic medical record ecosystem highlights various opportunities and growth spots for the coming decade.
The global medical automation market is estimated to secure a valuation of USD 48,626.2 million in 2023 and reach up to USD 103,052.3 million by 2033.
The global Portable Medical Devices Market is projected to expand at a CAGR of 10.7% during the forecast period.
The global Cardiac Assist Devices Market is poised to surpass USD 1.37 billion by 2023, surging at a remarkable CAGR of 6.1% through 2033 to reach USD 2.48 billion.
In a recently updated edition, trends infer a valuation of USD 1,175.10 million for the mobile cardiac telemetry system market in 2024. Looking ahead to 2034
The global cardiac surgery devices market is expected to enjoy a valuation of USD 1.7 Billion by the end of 2022
About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai and has delivery centres in the United Kingdom, the United States, and India. FMI's latest market research reports and industry analysis helps businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Join us as we commemorate 10 years of delivering trusted market insights. Reflecting on a decade of achievements, we continue to lead with integrity, innovation, and expertise.
Contact Us
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website:https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
SOURCE: Future Market Insights, Inc.
View the original press release on accesswire.com
